NanoViricides, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 8.59 million compared to USD 8.11 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.7 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | 0.00% | -1.79% | +7.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 12.96M | |
-2.53% | 103B | |
+1.77% | 95.28B | |
+1.57% | 22.15B | |
-15.39% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.23% | 16.05B | |
+3.98% | 13.68B | |
+34.71% | 12.17B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023